Search
for
Sort by
Research 91–120 of 1000+
- Activated Polyamine Catabolism Depletes Acetyl-CoA Pools and Suppresses Prostate Tumor Growth in TRAMP Mice
- Testosterone Deficiency is Not Protective Against the Development of Adenocarcinoma of the Prostate in a Type 1 Diabetic Patient
- Selenium or No Selenium- That Is the Question in Tumor Patients: A New Controversy
- Male pattern baldness and risk of colorectal neoplasia
- Review Article: Practical Aspects of Testosterone Deficiency Syndrome in Clinical Urology
- The secret identities of TMPRSS2: Fertility factor, virus trafficker, inflammation moderator, prostate protector and tumor suppressor
- Clinical Pearls in Men's Health
- Chapter 6. Darwinian Health and Other Contradictions
- The Enigma of the Stigma of Hair Loss: Why is Cancer-Treatment Related Alopecia so Traumatic for Women?
- Provenge is Talk of GU Malignancies Congress
- Tracing the cellular origin of cancer
- The Molecular Pathogenesis of Trichilemmal Carcinoma
- The Molecular Pathogenesis of Trichilemmal Carcinoma
- Perspectives in dermatopathology: telomeres and telomerase in ageing and cancer; with emphasis on cutaneous disease
- PAK4 signaling in health and disease: defining the PAK4–CREB axis
- The molecular pathogenesis of Trichilemmal carcinoma
- The role of dutasteride in the treatment of benign prostatic obstruction and related conditions
- The Double-Edged Proteins in Cancer Proteomes and the Generation of Induced Tumor-Suppressing Cells (iTSCs)
- Analysis of androgen receptor expression and activity in the mouse brain
- Finasteride Doesn't Shorten Survival in Long-term Study
- 5α-Reductase Inhibitors and Chemoprevention: The PCPT and Beyond
- Triple Hormonal Blockade (ADT3): A Patient’s Perspective
- Pharmacology and Potential Use of Cyproterone Acetate
- Androgen Receptor in Human Health: A Potential Therapeutic Target
- Ca <sup>2+</sup> -mediated protein citrullination regulates proliferation in the regenerating and malignant CNS
- A randomized phase II trial on the addition of dutasteride to combined androgen blockade therapy versus combined androgen blockade therapy alone in patients with advanced or metastatic salivary duct carcinoma – the DUCT study protocol
- Keeping Our Eye on the Ball: The American Society of Preventive Oncology in 2009
- Metformin and Malignant Tumors: Not Over the Hill
- Improving selective androgen receptor modulator discovery and preclinical evaluation
- Myricetin: A Significant Emphasis on Its Anticancer Potential via the Modulation of Inflammation and Signal Transduction Pathways